Grisnilimab
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-P99650-1MG | 1 mg | 521,00 | Add | |
| HY-P99650-5MG | 5 mg | 1'534,00 | Add | |
| HY-P99650-10MG | 10 mg | 2'420,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Grisnilimab (WT1), a IgG2a monoclonal antibody anti-CD7, is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA[1].
| Category | Antibody |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, s |
| Format | Solubility: 10 mM in DMSO |
| Grade | Clinical information: Phase 2 |
| CAS-Number | 2367001-70-3 |
| Disclaimer | Shipped on dry ice - extra freight charge will occur |
| Product Line | Biosimilar |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Dry Ice |
| Material Safety Data Sheet | Download PDF |
